ArticleThe Journal of infectious diseases2026

A Human Monoclonal Antibody Targeting α-Gal Ameliorates Experimental Cutaneous Leishmaniasis.

Hyeseon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.